Form 4 for BC BRUNSWICK CORP
Accepted 2023-11-01 00:00:00 ET · period of report 2023-10-31 · accession 0000014930-23-000192 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-01 | 2023-10-31 | BC | MCCLANATHAN JOSEPH W | Dir | A - Grant | $69.47 | +1,039 | 20.9K | +5% | +$72.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-31 | A | A | 1,039 | $69.47 | 20,910 | D | — | — | (F1) 454 of these shares are deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company. (F2) Beneficial holdings include 82 shares acquired pursuant to dividend reinvestments in September 2023. |